Kroger Co. (NYSE: KR) reported second-quarter results that painted a mixed picture for investors. While the grocery giant managed to beat earnings expectations and hold its full-year profit outlook steady, sales growth remained nearly stagnant, prompting management to lower its revenue guidance for the fiscal year.
Sales Growth Stalls
For the quarter ended August 15, identical sales excluding fuel rose a mere 0.2%, a sharp slowdown that underscores the challenges facing the supermarket chain. Total sales, however, climbed to $34.6 billion from $33.9 billion in the same period last year, roughly in line with analyst projections. The company cited a 138-basis-point drag from changes related to the Inflation Reduction Act, which impacted pharmacy sales. Excluding that effect and other one-time items, underlying sales growth was just 0.1%, indicating persistent softness in core grocery demand.
Earnings Beat, Guidance Maintained
Despite the sales slowdown, Kroger reported adjusted earnings of $1.09 per share, up from $1.04 a year ago and above the consensus estimate of $1.06. Management reaffirmed its full-year adjusted EPS guidance of $5.10 to $5.30, along with its outlook for adjusted FIFO operating profit of $5.0 billion to $5.2 billion. The company also maintained its free cash flow guidance of $2.7 billion to $2.9 billion and capital spending plans of $3.8 billion to $4.0 billion.
Margin Pressures and Operational Gains
Gross margin contracted by 10 basis points to 22.4% of sales, but on an adjusted FIFO basis, the margin rate improved by 13 basis points, helped by stronger e-commerce profitability, retail media growth, and better pharmacy mix. However, these gains were partially offset by higher shrink, transportation costs, and increased investment in customer value. Operating expenses rose 33 basis points due to wage inflation, healthcare costs, and weak sales leverage.
Digital and Media Bright Spots
Kroger's e-commerce sales surged 20% on an adjusted basis, and its retail media business, Kroger Precision Marketing, saw profits jump 24%. These segments are becoming increasingly important as they provide higher-margin revenue streams and deeper customer insights.
Balance Sheet and Capital Returns
The company repurchased $1.0 billion worth of shares during the quarter, leaving $800 million under its authorization. It also raised its dividend by 11%, marking the 20th consecutive annual increase. Net debt to adjusted EBITDA rose to 1.91 from 1.63 a year earlier, still within the company's target range of 2.30 to 2.50.
Investor Outlook
With the stock trading at roughly 11 times the midpoint of its EPS guidance, the valuation appears reasonable if earnings are sustainable. However, the muted sales growth raises concerns about future profitability. The company's investor update on October 20 will be crucial, as management is expected to provide more details on strategic initiatives and long-term financial targets. Investors will be watching to see if the sales slowdown is truly pharmacy-related and whether Kroger can continue to grow e-commerce profitably.
